(R)-Nepicastat HCl [RS-25560-198 HCl]
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CAS NO: | 195881-94-8 |
规格: | ≥98% |
包装与价格:
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
产品介绍
理化性质和储存条件
Molecular Weight (MW) | 331.81 |
---|
Formula | C14H15F2N3S.HCl |
---|
CAS No. | 195881-94-8 |
---|
Storage | -20℃ for 3 years in powder form |
---|
-80℃ for 2 years in solvent |
Solubility (In vitro) | DMSO: 66 mg/mL (198.9 mM) |
---|
Water: <1 mg/mL |
Ethanol: <1 mg/mL |
Solubility (In vivo) | 30% propylene glycol, 5% Tween 80, 65% D5W: 30 mg/mL |
---|
Synonyms | RS-25560-198 HCl; RS-25560 198 HCl; RS 25560-198 HCl; RS25560-198 HCl |
---|
SMILES Code | S=C1N([C@H]2CC3=C(C(F)=CC(F)=C3)CC2)C(CN)=CN1.[H]Cl |
---|
实验参考方法
In Vitro | In vitro activity: (R)-Nepicastat produces concentration-dependent inhibition of bovine and human dopamine-β-hydroxylase activity in vitro. |
---|
In Vivo | (R)-Nepicastat (30 mg/kg, p.o.) reduces noradrenaline content, dopamine content and dopamine/noradrenaline ratio in mesenteric artery and left ventricle of spontaneously hypertensive rats (SHRs). |
---|
Animal model | Animal Models Spontaneously hypertensive rats (SHRs). |
---|
Formulation & Dosage | Dissolved in distilled water; 30 mg/kg; p.o. |
---|
References | Br J Pharmacol. 1997 Aug;121(8):1803-9. |
---|